Otcqb Podcast

Alpha Cognition Inc.

Informações:

Sinopse

Alpha Cognition Inc. (OTCQB: ACGOF) is a clinical stage, biopharmaceutical company dedicated to developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and ALS. CEO Michael McFadden joins us to break down the types of neurodegenerative diseases that are targeted in the company’s programs.